MedPath

Whole-Exome Sequencing in Dutch Children with PSC

Completed
Conditions
Primary Sclerosing Cholangitis
10017969
10019654
Registration Number
NL-OMON46010
Lead Sponsor
niversitair Medisch Centrum Groningen
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
150
Inclusion Criteria

This study involves two groups of participants:
(1) An affected individual who developed PSC before the age of 13, and in whom PSC was confirmed with either cholangiography or liver biopsy
(2) Parents of participants of group 1 ;Eligible candidates of group 1 can have any age.
Confirmation of PSC by imaging is defined as the presence of multifocal strictures, focal dilatation, or beading of the biliary tree. Histological confirmation is defined as the presence of bile duct damage, onion-skinned peri-ductal fibrosis, inflammation, portal edema or fibrosis, ductopenia, ductular proliferation, or cholestasis

Exclusion Criteria

Patients with PSC due to secondary causes such as surgery, trauma, cancer or infection will be excluded from participation in this study

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Identification of rare coding variants of large effect that predict early-onset<br /><br>PSC</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Not applicable</p><br>
© Copyright 2025. All Rights Reserved by MedPath